GENE ONLINE|News &
Opinion
Blog

M&A
M&A Rare Disease
AstraZeneca to Acquire Alexion for US$ 39 Billion to Grow Immunology Pipeline
2020-12-13
COVID-19 Recombinant Fusion Protein
Merck Spends $425 Million to Acquire OncoImmune’s COVID-19 Therapy
2020-11-24
M&A Type 2 Diabetes
Novo Nordisk’s Acquisition of Emisphere Could Embolden Diabetics to Cut Back on Needles
2020-11-08
M&A B-cell Lymphoma
Hot Pursuit for Antibody Drug Conjugates Continue as Merck Acquires VelosBio
2020-11-06
M&A Cancer
Sanofi Offers to Buy Kiadis Pharma to Advance Immuno-Oncology Research
2020-11-03
M&A CRISPR
Why is PerkinElmer Buying Horizon Discovery?
2020-11-02
M&A Gene Therapy
Novartis Expands Foothold in Gene Therapy With New Acquisition
2020-10-30
M&A Early Cancer Detection
Exact Sciences Looks to Thrive in Blood-Based, Early Cancer Detection Space with Two New Buyouts
2020-10-29
M&A Beta-Lactamase
Pfizer Expands Antibacterial Portfolio by Acquiring Antibiotic Drug Maker
2020-10-28
M&A Gene Therapy
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
R&D Rare Disease
Retrophin Acquires Orphan Technologies to Develop Potential, Effective Cure for Rare Disease
2020-10-25
M&A SARM1
Eli Lilly Intends to Disarm Axonal Degeneration with Newest Acquisition
2020-10-17
M&A In Situ Analysis
With Two New Buyouts, 10X Genomics Places Bet on Emerging In Situ Field
2020-10-09
Funding Heart Disease
Why is Bristol Myers Squibb Investing $13.1 Billion in MyoKardia?
2020-10-06
M&A Kidney Disease
Chinook Therapeutics Completes Merger with Aduro BioTech Inc.
2020-10-05
1 … 10 11 12 13 14
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top